Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Anacor Pharmaceuticals, Inc. (ANAC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/11/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 07/05/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 06/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/24/2016 |
4
| Shapiro Lucy (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| RIEFLIN WILLIAM JL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 89,000 shares
@ $99.25, valued at
$8.8M
Disposed/sold 853 shares
@ $99.25, valued at
$84.7k
Disposed/sold 4,403 options to buy
@ $69.4, valued at
$305.6k
|
|
| 06/24/2016 |
4
| LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 794 shares
@ $99.25, valued at
$78.8k
Disposed/sold 30,000 options to buy
@ $6.92, valued at
$207.6k
Disposed/sold 24,000 options to buy
@ $6.74, valued at
$161.8k
Disposed/sold 15,000 options to buy
@ $5.2, valued at
$78k
Disposed/sold 15,000 options to buy
@ $5.11, valued at
$76.7k
Disposed/sold 15,000 options to buy
@ $14.22, valued at
$213.3k
Disposed/sold 4,096 options to buy
@ $69.4, valued at
$284.3k
|
|
| 06/24/2016 |
4
| Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 794 shares
@ $99.25, valued at
$78.8k
Disposed/sold 27,000 options to buy
@ $25.48, valued at
$688k
Disposed/sold 4,096 options to buy
@ $69.4, valued at
$284.3k
|
|
| 06/24/2016 |
4
| Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| BERNS PAUL L (President and CEO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/24/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/24/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/24/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/24/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/24/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/24/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 06/24/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 06/24/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 06/24/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 06/24/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 06/24/2016 |
8-K
| Quarterly results |
| 06/24/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 06/08/2016 |
8-K
| Form 8-K - Current report |
| 06/07/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 06/03/2016 |
4
| Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 05/26/2016 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 05/26/2016 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 05/24/2016 |
4
| Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 05/19/2016 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
|
|
|